Abstract
Mycophenolic acid, an inhibitor of purine metabolism, was shown to block the replication of vaccinia virus in normal cell lines. This observation led to the development of a dominant one-step plaque selection system, based on expression of the Escherichia coli gpt gene, for the isolation of recombinant vaccinia viruses. Synthesis of xanthine-guanine phosphoribosyltransferase enabled only the recombinant viruses to form large plaques in a selective medium containing mycophenolic acid, xanthine, and hypoxanthine. To utilize the selection system efficiently, we constructed a series of plasmids that contain the E. coli gpt gene and allow insertion of foreign genes into multiple unique restriction endonuclease sites in all three reading frames between the translation initiation codon of a strong late promoter and synthetic translation termination sequences. The selection-expression cassette is flanked by vaccinia virus DNA that directs homologous recombination into the virus genome. The new vectors allow high-level expression of complete or partial open reading frames and rapid construction of recombinant viruses by facilitating the cloning steps and by simplifying their isolation. The system was tested by cloning the E. coli beta-galactosidase gene; in 24 h, this enzyme accounted for approximately 3.5% of the total infected-cell protein.
MeSH Terms
Cloning, Molecular/methods
DNA, Recombinant
Escherichia coli/genetics
Gene Expression Regulation
Genetic Vectors
Mycophenolic Acid/pharmacology
Pentosyltransferases/genetics
Promoter Regions, Genetic
Recombinant Proteins/genetics
Regulatory Sequences, Nucleic Acid
Selection, Genetic
Vaccinia virus/genetics
Virus Replication/drug effects
beta-Galactosidase/genetics
Chemicals
DNA, Recombinant
Recombinant Proteins
Pentosyltransferases
xanthine phosphoribosyltransferase
beta-Galactosidase
Mycophenolic Acid
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Falkner F G
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Moss B
References (25)
25 references, click to expand
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem. 1976 May 7;72:248-54
PMID: 942051
-
Non-producer human cells induced by murine sarcoma virus.
Int J Cancer. 1975 Jan 15;15(1):23-9
PMID: 165148
-
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7415-9
PMID: 6296831
-
Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5364-8
PMID: 6310573
-
New versatile plasmid vectors for expression of hybrid proteins coded by a cloned gene fused to lacZ gene sequences encoding an enzymatically active carboxy-terminal portion of beta-galactosidase.
Gene. 1983 Nov;25(1):71-82
PMID: 6319233
-
Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome.
J Virol. 1984 Feb;49(2):371-8
PMID: 6319738
-
In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.
J Virol. 1985 Apr;54(1):30-7
PMID: 3973982
-
One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription.
Proc Natl Acad Sci U S A. 1985 Apr;82(7):2096-100
PMID: 3856886
-
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
Nature. 1985 Oct 31-Nov 6;317(6040):813-5
PMID: 4058585
-
Dideoxy sequencing method using denatured plasmid templates.
Anal Biochem. 1986 Feb 1;152(2):232-8
PMID: 3516005
-
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
Mol Cell Biol. 1985 Dec;5(12):3403-9
PMID: 3939316
-
Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.
Mol Cell Biol. 1985 Aug;5(8):1918-24
PMID: 3018537
-
Vaccinia virus expression vectors.
J Gen Virol. 1986 Oct;67 ( Pt 10):2067-82
PMID: 3531399
-
Oligonucleotide-directed double-strand break repair in plasmids of Escherichia coli: a method for site-specific mutagenesis.
Proc Natl Acad Sci U S A. 1986 Oct;83(19):7177-81
PMID: 3532104
-
Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.
J Virol. 1986 Nov;60(2):436-49
PMID: 3021979
-
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6
PMID: 3095828
-
Detection of genotoxic properties of mycotoxins with the SOS chromotest.
Naturwissenschaften. 1986 Nov;73(11):677-8
PMID: 3543698
-
Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression.
Gene. 1986;47(2-3):193-9
PMID: 3104141
-
Vaccinia virus expression vectors.
Annu Rev Immunol. 1987;5:305-24
PMID: 2439103
-
Vaccinia virus produces late mRNAs by discontinuous synthesis.
Cell. 1987 Jul 17;50(2):153-62
PMID: 3036368
-
Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5' poly(A) leader.
Cell. 1987 Jul 17;50(2):163-9
PMID: 3594569
-
Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.
Mol Cell Biol. 1987 Jul;7(7):2538-44
PMID: 3112559
-
In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence.
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8883-7
PMID: 2827158
-
Isolation of high-molecular-weight DNA from mammalian cells.
Eur J Biochem. 1973 Jul 2;36(1):32-8
PMID: 4200179
-
Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2072-6
PMID: 7017722